Mesoblast revenue and financials
In the fiscal year ended June 2026, Mesoblast reported revenue of $120.25M (+599.21% year over year). The net loss was $57.5M.
Fiscal year ending in June. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +599.21%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- -47.8%
- FY to Jun 2025: -593.9%
How Mesoblast is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 74.5% a year on average over the last 5 years
Compound annual growth rate: from $7.43M in 2021 to $120.25M in 2026.
Operating margin rose from −923.7% to −42.6%
Operating income over revenue, 2023 → 2026: 881.1 percentage points.
Shares outstanding up 114.0% in 5 years
Average diluted shares, 2021 → 2026: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 0 of 5 fiscal years
Positive net income, fiscal years 2022–2026.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 120 | 17.2 | 5.9 | 7.5 | 10.2 | 7.4 | 32.2 | 16.7 | 17.3 | 2.4 |
| Cost of revenue | 24.0 | 17.6 | 3.0 | 52.8 | 63.6 | 85.7 | 81.5 | 75.2 | 71.4 | 12.1 |
| Gross profit | 96.2 | -0.4 | 3.0 | -45.3 | -53.4 | -78.3 | -49.3 | -58.5 | -54.1 | -9.7 |
| Selling, general and administrative | 57.3 | 39.3 | 25.0 | 27.5 | 27.2 | 30.9 | 25.6 | 21.6 | 21.9 | 23.0 |
| Research and development | 90.1 | 22.3 | 36.8 | 52.8 | — | — | — | — | — | 58.9 |
| Operating income | -51.3 | -62.4 | -58.1 | -69.3 | -80.6 | -109 | -74.9 | -80.2 | -74.9 | -90.0 |
| EBIT | -51.3 | -62.4 | -58.1 | -69.3 | -80.6 | -109 | -74.9 | -80.2 | -74.9 | -90.0 |
| EBITDA | -44.6 | -58.2 | -56.2 | -66.8 | -77.9 | -107 | -72.7 | -78.1 | -72.2 | -87.0 |
| Interest expense | 19.9 | 21.8 | 20.7 | 19.4 | 16.9 | 15.9 | 14.7 | 11.7 | 1.8 | — |
| Pre-tax income | -56.9 | -102 | -88.1 | -82.1 | -91.6 | -99.6 | -87.4 | -98.8 | -66.0 | -90.2 |
| Income tax | 0.6 | 0.3 | -0.2 | -0.2 | -0.2 | -0.8 | -9.4 | -9.0 | -30.7 | -13.4 |
| Net income | -57.5 | -102 | -88.0 | -81.9 | -91.3 | -98.8 | -77.9 | -89.8 | -35.3 | -76.8 |
| Net income to common shareholders | -57.5 | -102 | -88.0 | -81.9 | -91.3 | -98.8 | -77.9 | -89.8 | -35.3 | -76.8 |
| Basic EPS | -0.04 | -0.08 | -0.09 | -0.11 | -0.13 | -0.16 | -0.15 | -0.18 | -0.08 | -0.19 |
| Diluted EPS | -0.04 | -0.08 | -0.09 | -0.11 | -0.13 | -0.16 | -0.15 | -0.18 | -0.08 | -0.19 |
| Average shares (basic) | 1,295 | 1,208 | 987 | 778 | 683 | 605 | 529 | 494 | 466 | 395 |
| Average shares (diluted) | 1,295 | 1,208 | 987 | 778 | 683 | 605 | 529 | 494 | 466 | 395 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 68.9 | 51.3 | 14.0 | 3.2 | 2.5 | 3.4 | 4.1 | 3.4 | 4.2 | 6.0 |
| Cost of revenue | -29.7 | 53.8 | 12.5 | 5.1 | 31.9 | 7.9 | 28.7 | 26.2 | 29.9 | 33.7 |
| Gross profit | 98.6 | -2.4 | 1.5 | -1.9 | -29.4 | -4.5 | -24.7 | -22.8 | -25.7 | -27.7 |
| Selling, general and administrative | 28.8 | 28.5 | 21.3 | 18.0 | 13.5 | 11.5 | 12.1 | 13.3 | 13.5 | 13.7 |
| Research and development | 90.1 | — | 22.3 | — | -11.5 | 11.5 | — | — | — | — |
| Operating income | -22.9 | -28.3 | -42.5 | -20.0 | -31.4 | -26.6 | -33.5 | -35.8 | -39.1 | -41.4 |
| EBIT | -22.9 | -28.3 | -42.5 | -20.0 | -31.4 | -26.6 | -33.5 | -35.8 | -39.1 | -41.4 |
| EBITDA | -19.5 | -25.1 | -39.3 | -18.9 | -30.5 | -25.6 | -32.3 | -34.5 | -37.8 | -40.1 |
| Interest expense | 8.6 | 11.3 | 11.1 | 10.7 | 10.5 | 10.2 | 10.0 | 9.5 | 8.7 | 8.2 |
| Pre-tax income | -17.2 | -39.7 | -54.1 | -47.7 | -55.5 | -32.6 | -40.6 | -41.5 | -42.9 | -48.7 |
| Income tax | 0.2 | 0.4 | 0.1 | 0.2 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 |
| Net income | -17.3 | -40.2 | -54.2 | -47.9 | -55.4 | -32.5 | -40.5 | -41.4 | -42.8 | -48.6 |
| Net income to common shareholders | -17.3 | -40.2 | -54.2 | -47.9 | -55.4 | -32.5 | -40.5 | -41.4 | -42.8 | -48.6 |
| Basic EPS | -0.01 | -0.03 | -0.04 | -0.04 | -0.05 | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 |
| Diluted EPS | -0.01 | -0.03 | -0.04 | -0.04 | -0.05 | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 |
| Average shares (basic) | 1,298 | 1,292 | 1,273 | 1,142 | 1,098 | 875 | 822 | 733 | 650 | 648 |
| Average shares (diluted) | 1,298 | 1,292 | 1,273 | 1,142 | 1,098 | 875 | 822 | 733 | 650 | 648 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 773 | 785 | 669 | 669 | 662 | 745 | 734 | 652 | 692 | 656 |
| Current assets | 197 | 204 | 86.5 | 81.7 | 69.8 | 148 | 137 | 62.5 | 101 | 63.6 |
| Cash and equivalents | 103 | 162 | 63.0 | 71.3 | 60.4 | 137 | 129 | 50.4 | 37.8 | 45.8 |
| Receivables | 57.7 | 14.9 | 20.5 | 6.5 | 3.9 | 4.1 | 0.9 | 3.3 | 49.6 | 3.0 |
| Inventory | 28.1 | 22.2 | 0.0 | — | — | — | — | — | — | — |
| Net property, plant and equipment | 8.0 | 5.8 | 3.8 | 6.5 | 10.0 | 12.1 | 10.3 | 0.8 | 1.1 | 1.8 |
| Goodwill | 134 | 134 | 134 | 134 | 134 | 134 | 134 | 134 | 134 | 134 |
| Other intangible assets | 432 | 437 | 441 | 443 | 444 | 446 | 447 | 449 | 450 | 452 |
| Long-term investments | 0.0 | 1.4 | 1.0 | 1.8 | 1.8 | 2.1 | 1.9 | 2.3 | 2.3 | 2.0 |
| Current liabilities | 81.1 | 103 | 73.2 | 42.0 | 51.4 | 94.3 | 90.1 | 44.3 | 24.0 | 36.7 |
| Accounts payable | 34.5 | 18.1 | 7.1 | 20.1 | 23.1 | 19.6 | 25.0 | 13.1 | 18.9 | 21.8 |
| Long-term debt | 109 | 67.7 | 100 | 103 | 91.6 | 41.0 | 57.0 | 67.3 | 59.4 | — |
| Total debt | 127 | 128 | 119 | 116 | 107 | 105 | 99.3 | 81.3 | 59.4 | — |
| Total liabilities | 205 | 187 | 189 | 168 | 165 | 163 | 184 | 171 | 146 | 139 |
| Total equity (incl. minority) | 568 | 597 | 480 | 502 | 497 | 581 | 549 | 481 | 546 | 517 |
| Retained earnings | -1,068 | -1,011 | -909 | -821 | -739 | -648 | -549 | -470 | -380 | -345 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 773 | 782 | 785 | 653 | 669 | 670 | 669 | 668 | 662 | 704 |
| Current assets | 197 | 202 | 204 | 69.7 | 86.5 | 85.2 | 81.7 | 78.1 | 69.8 | 109 |
| Cash and equivalents | 103 | 130 | 162 | 38.0 | 63.0 | 77.6 | 71.3 | 67.6 | 60.4 | 94.8 |
| Receivables | 57.7 | 43.3 | 14.9 | 2.9 | 20.5 | 3.5 | 6.5 | 3.8 | 3.9 | 5.6 |
| Inventory | 28.1 | 21.7 | 22.2 | 24.2 | — | — | — | — | — | — |
| Net property, plant and equipment | 8.0 | 8.3 | 5.8 | 6.2 | 3.8 | 5.5 | 6.5 | 8.2 | 10.0 | 11.5 |
| Goodwill | 134 | 134 | 134 | 134 | 134 | 134 | 134 | 134 | 134 | 134 |
| Other intangible assets | 432 | 434 | 437 | 440 | 441 | 442 | 443 | 443 | 444 | 445 |
| Long-term investments | 0.0 | 1.6 | 1.4 | 1.2 | 1.0 | 0.8 | 1.8 | 1.9 | 1.8 | 2.3 |
| Current liabilities | 81.1 | 128 | 103 | 72.8 | 73.2 | 31.4 | 42.0 | 54.6 | 51.4 | 58.0 |
| Accounts payable | 34.5 | 27.1 | 18.1 | 11.9 | 7.1 | 10.8 | 20.1 | 23.0 | 23.1 | 20.9 |
| Long-term debt | 109 | 60.1 | 67.7 | 101 | 100 | 107 | 103 | 97.0 | 91.6 | 86.5 |
| Total debt | 127 | 135 | 128 | 126 | 119 | 122 | 116 | 112 | 107 | 103 |
| Total liabilities | 205 | 208 | 187 | 192 | 189 | 162 | 168 | 168 | 165 | 169 |
| Total equity (incl. minority) | 568 | 575 | 597 | 461 | 480 | 509 | 502 | 500 | 497 | 536 |
| Retained earnings | -1,068 | -1,051 | -1,011 | -957 | -909 | -853 | -821 | -780 | -739 | -696 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -43.8 | -50.0 | -48.5 | -63.3 | -65.8 | -101 | -56.4 | -57.8 | -75.0 | -95.5 |
| Depreciation and amortization | 8.6 | 6.4 | 4.7 | 4.1 | 4.4 | 4.3 | 3.7 | 2.1 | 2.7 | 3.1 |
| Capital expenditure | -0.8 | -0.7 | -0.3 | -0.3 | -0.2 | -1.6 | -2.1 | -0.3 | -0.2 | -0.3 |
| Investing cash flow | -1.0 | 0.1 | -0.1 | -0.2 | -0.2 | -1.6 | -3.3 | -1.0 | -1.2 | 0.1 |
| Financing cash flow | -15.3 | 147 | 40.3 | 74.5 | -9.9 | 109 | 137 | 71.6 | 68.6 | 60.0 |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — |
| Debt issued | 121 | 0.0 | 0.0 | 0.0 | 51.9 | — | 0.5 | 43.6 | 31.7 | — |
| Debt repaid | -127 | -9.8 | -13.5 | -2.7 | -58.2 | -2.9 | -2.1 | — | — | — |
| Effect of exchange rates | 1.5 | 1.1 | -0.1 | -0.2 | -0.6 | 1.4 | 1.5 | -0.2 | -0.4 | 0.1 |
| Net change in cash | -58.6 | 98.6 | -8.4 | 10.9 | -76.4 | 7.6 | 78.9 | 12.7 | -8.0 | -35.2 |
| Free cash flow | -44.7 | -50.6 | -48.7 | -63.5 | -65.9 | — | — | — | — | — |
| Levered free cash flow | -52.0 | -55.1 | -27.4 | -60.2 | -44.3 | -83.0 | -18.3 | 6.9 | -97.4 | -51.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -13.5 | -30.3 | -29.3 | -20.7 | -21.9 | -26.6 | -32.5 | -30.7 | -29.4 | -36.4 |
| Depreciation and amortization | 4.3 | 4.3 | 4.3 | 2.1 | 2.2 | 2.4 | 1.9 | 2.2 | 2.2 | 2.2 |
| Capital expenditure | -0.4 | -0.4 | -0.6 | -0.1 | -0.1 | -0.2 | -0.1 | -0.2 | -0.1 | -0.1 |
| Investing cash flow | -0.4 | -0.6 | -0.5 | 0.6 | -0.0 | -0.1 | 0.0 | -0.2 | -0.1 | -0.1 |
| Financing cash flow | -14.2 | -1.1 | 152 | -4.3 | 8.7 | 31.6 | 36.2 | 38.3 | -4.8 | -5.1 |
| Dividends paid | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — |
| Debt issued | 50.0 | 71.4 | — | — | — | — | — | — | 0.0 | 51.9 |
| Debt repaid | -56.8 | -70.5 | -6.2 | -3.6 | -11.4 | -2.1 | -1.5 | -1.1 | -1.6 | -56.7 |
| Effect of exchange rates | 1.0 | 0.5 | 1.7 | -0.6 | -1.4 | 1.3 | -0.0 | -0.1 | -0.1 | -0.4 |
| Net change in cash | -27.1 | -31.6 | 124 | -24.9 | -14.6 | 6.2 | 3.7 | 7.2 | -34.4 | -42.0 |
| Free cash flow | -13.9 | -30.8 | -29.9 | -20.8 | -22.0 | -26.8 | -32.6 | -30.9 | -29.4 | -36.5 |
| Levered free cash flow | -23.6 | -28.4 | -41.1 | -14.1 | 0.5 | -27.8 | -36.1 | -24.0 | -26.4 | -18.0 |
Financial statements of similar companies
Companies in the group: same industry, similar size
